AMPK β1 activation suppresses antipsychotic-induced hyperglycemia in mice

Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene

(2019) Yamei Han et al.   Nature Communications

Subcutaneous inguinal white adipose tissue is responsive to, but dispensable for, the metabolic health benefits of exercise

(2018) Willem T. Peppler et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis

(2018) Natasha D. Bush et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Obesity exacerbates the acute metabolic side effects of olanzapine

(2018) Logan K. Townsend et al.   PSYCHONEUROENDOCRINOLOGY

Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice

(2018) Laura N. Castellani et al.   Scientific Reports

Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia

(2017) Laura N. Castellani et al.   PSYCHONEUROENDOCRINOLOGY

Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function

(2016) Emilio P. Mottillo et al.   Cell Metabolism

Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1

(2016) Brennan K. Smith et al.   DIABETES

AMPK Phosphorylates Desnutrin/ATGL and Hormone-Sensitive Lipase To Regulate Lipolysis and Fatty Acid Oxidation within Adipose Tissue

(2016) Sun-Joong Kim et al.   MOLECULAR AND CELLULAR BIOLOGY

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

(2016) Rudolph M. Navari et al.   NEW ENGLAND JOURNAL OF MEDICINE

AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B

(2016) M. Johanns et al.   Nature Communications

Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis

(2015) Yoshinori Takeuchi et al.   DRUG SAFETY

Metformin attenuates olanzapine-induced hepatic, but not peripheral insulin resistance

(2015) Gary J Remington et al.   JOURNAL OF ENDOCRINOLOGY

Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology

(2015) Leonel E. Rojo et al.   PHARMACOLOGICAL RESEARCH

Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia

(2015) Ariel Graff-Guerrero et al.   JAMA Psychiatry

Prior AICAR Stimulation Increases Insulin Sensitivity in Mouse Skeletal Muscle in an AMPK-Dependent Manner

(2015) Rasmus Kjøbsted et al.   DIABETES

Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice

(2014) Rebecca E. K. MacPherson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPKin Vivo

(2014) Clinton M. Hasenour et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Approach to assessing determinants of glucose homeostasis in the conscious mouse

(2014) Curtis C. Hughey et al.   MAMMALIAN GENOME

Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats

(2014) Yueshan Hu et al.   PLoS One

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects

(2014) Nevena Divac et al.   Biomed Research International

Stain-Free total protein staining is a superior loading control to β-actin for Western blots

(2013) Jennifer E. Gilda et al.   ANALYTICAL BIOCHEMISTRY

Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′-monophosphate-activated protein kinase

(2013) M. Ikegami et al.   DIABETES OBESITY & METABOLISM

Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance

(2013) Chao Deng   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls

(2013) Margaret Karolina Hahn et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Evidence for the role of AMPK in regulating PGC-1 alpha expression and mitochondrial proteins in mouse epididymal adipose tissue

(2013) Zhongxiao Wan et al.   Obesity

Second-Generation Antipsychotics Cause a Rapid Switch to Fat Oxidation That Is Required for Survival in C57BL/6J Mice

(2013) C. M. Klingerman et al.   SCHIZOPHRENIA BULLETIN

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain

(2012) Renan P. Souza et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats

(2012) Heidi Boyda et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase

(2012) S. A. Hawley et al.   SCIENCE

AMPK functions as an adenylate charge-regulated protein kinase

(2012) Jonathan S. Oakhill et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults

(2011) Alicia Ruelaz Maher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers

(2011) Vance L. Albaugh et al.   PLoS One

Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat

(2011) Goran Jassim et al.   PSYCHOPHARMACOLOGY

Reversible Ponceau staining as a loading control alternative to actin in Western blots

(2010) Isabel Romero-Calvo et al.   ANALYTICAL BIOCHEMISTRY

Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting

(2010) Ric M. Procyshyn et al.   JOURNAL OF CLINICAL PSYCHIATRY

Nonshivering thermogenesis and its adequate measurement in metabolic studies

(2010) B. Cannon et al.   JOURNAL OF EXPERIMENTAL BIOLOGY

Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in Rodents

(2010) Vance L. Albaugh et al.   SCHIZOPHRENIA BULLETIN

AMPK β1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance

(2009) Nicolas Dzamko et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

30 Days of Continuous Olanzapine Infusion Determines Energy Imbalance, Glucose Intolerance, Insulin Resistance, and Dyslipidemia in Mice

(2009) Roberto Coccurello et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model

(2009) Araba F. Chintoh et al.   SCHIZOPHRENIA RESEARCH

The use of total protein stains as loading controls: An alternative to high-abundance single-protein controls in semi-quantitative immunoblotting

(2008) Georgina M. Aldridge et al.   JOURNAL OF NEUROSCIENCE METHODS